Treatment of Hepatitis B Virus-Associated Membranous Nephropathy: Lamivudine Era versus Post-Lamivudine Era

참고문헌 (10)

1. Bhimma R, "Hepatitis B virus-associated nephropathy", Am J Nephrol, 24, pp.198~211 (2004)
2. Liao MT, "Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy", Pediatrics, 128, pp.e600~e604 (2011)
3. Lai KN, "Membranous nephropathy related to hepatitis B virus in adults", N Engl J Med, 324, pp.1457~1463 (1991)
4. Yi Z, "The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: a systematic review and meta-analysis", Ann Hepatol, 10, pp.165~173 (2011)
5. Zheng XY, "Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis", World J Gastroenterol, 18, pp.821~832 (2012)
6. 선인오, "Experience of Anti-Viral Therapy in Hepatitis B-Associated Membranous Nephropathy, Including Lamivudine-Resistant Strains", The Korean Journal of Internal Medicine, 27(4), pp.411~416 (2012), 대한내과학회[DOI]
7. Chang TT, "A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B", N Engl J Med, 354, pp.1001~1010 (2006)
8. Ebata S, "A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler’s disease", Clin Exp Nephrol, 16, pp.805~810 (2012)
9. Lai KN, "The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia", Nephron, 54, pp.12~17 (1990)
10. Shin SK, "Comparison between lamivudine alone and lamivudine and steroid combination in treatment of nephrotic syndrome associated with hepatitis B", Korean J Nephrol, 18, pp.550~559 (1999)

관련 논문AI추천